CGAS and viral infectious disease: Studies have found that interfering with SPSB3, a cGAS substrate receptor, to regulate the degradation of nuclear cGAS can activate the IFN-1 signaling pathway, providing new insights and potential therapeutic avenues for combating viral infections [121].